Literature DB >> 20842599

Electrical stimulation in epilepsy: vagus nerve and brain stimulation.

Barbara C Jobst1.   

Abstract

OPINION STATEMENT: Vagus nerve stimulation (VNS) for epilepsy is a well established and effective treatment for medically intractable epilepsy. VNS is indicated if resective epilepsy surgery is unsuccessful or is not an option. About 50% of patients with VNS have a seizure reduction greater than 50%, but less than 10% become seizure-free. VNS also has an alerting effect on patients and may allow a reduction in sedating medications. The major adverse event is hoarseness, but treatment is generally well tolerated. The therapeutic effect can be delayed: patients may improve several months after VNS implantation. Direct brain stimulation (DBS) is an emerging treatment for epilepsy. Scheduled stimulation is similar to brain stimulation in Parkinson's disease. Only the anterior thalamic nucleus has been studied in a larger randomized, controlled trial, in which patients with the stimulator turned on had a significantly reduced seizure frequency. Responsive stimulation applies an electrical stimulus at the site of seizure onset to terminate the seizure if one occurs. The seizure-onset zone must be well defined before implantation. Responsive stimulation requires seizure detection and application of a stimulus online. A large pivotal trial showed a significant reduction in seizure frequency. Both DBS and responsive neurostimulation are well tolerated, but there has been some concern about depression with DBS. Infection, hemorrhage, and lead breakage are adverse events possible with any type of stimulator. None of the brain stimulation devices have been approved by the US Food and Drug Administration, but final approval is expected soon. These devices are indicated for patients with bilateral seizure onset or seizure onset in eloquent areas. Although the initial trials of brain stimulation do not show overwhelming improvement in seizure frequency, the technology will improve with time as we continue to learn about the use of brain stimulation for epilepsy. Optimization of VNS has been going on for 10 years, and we need to ensure that brain stimulation is similarly developed further. In addition, sophisticated devices such as responsive neurostimulators can greatly enhance our understanding of the pathophysiology of epilepsy.

Entities:  

Year:  2010        PMID: 20842599     DOI: 10.1007/s11940-010-0087-4

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  40 in total

1.  High frequency thalamic stimulation for inoperable mesial temporal epilepsy.

Authors:  Ivan Osorio; John Overman; Jonathon Giftakis; Steven B Wilkinson
Journal:  Epilepsia       Date:  2007-03-26       Impact factor: 5.864

2.  Refractory generalized seizures: response to corpus callosotomy and vagal nerve stimulation.

Authors:  Maromi Nei; Michael O'Connor; Joyce Liporace; Michael R Sperling
Journal:  Epilepsia       Date:  2006-01       Impact factor: 5.864

3.  Chronic bilateral stimulation of the anterior thalamus of kainate-treated rats increases seizure frequency.

Authors:  Fred A Lado
Journal:  Epilepsia       Date:  2006-01       Impact factor: 5.864

4.  Vagus nerve stimulation in 15 children with therapy resistant epilepsy; its impact on cognition, quality of life, behaviour and mood.

Authors:  Tove Hallböök; Johan Lundgren; Karin Stjernqvist; Gösta Blennow; Lars-Göran Strömblad; Ingmar Rosén
Journal:  Seizure       Date:  2005-09-19       Impact factor: 3.184

5.  Vagus nerve stimulation for refractory epilepsy: a transatlantic experience.

Authors:  Kristl Vonck; Vijay Thadani; Karen Gilbert; Stefanie Dedeurwaerdere; Liesbeth De Groote; Veerle De Herdt; Lut Goossens; Fleur Gossiaux; Erik Achten; Evert Thiery; Guy Vingerhoets; Dirk Van Roost; Jacques Caemaert; Jacques De Reuck; David Roberts; Peter Williamson; Paul Boon
Journal:  J Clin Neurophysiol       Date:  2004 Jul-Aug       Impact factor: 2.177

6.  Deep brain stimulation in patients with refractory temporal lobe epilepsy.

Authors:  Paul Boon; Kristl Vonck; Veerle De Herdt; Annelies Van Dycke; Maarten Goethals; Lut Goossens; Michel Van Zandijcke; Tim De Smedt; Isabelle Dewaele; Rik Achten; Wytse Wadman; Frank Dewaele; Jacques Caemaert; Dirk Van Roost
Journal:  Epilepsia       Date:  2007-08       Impact factor: 5.864

7.  Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group.

Authors:  E Ben-Menachem; R Mañon-Espaillat; R Ristanovic; B J Wilder; H Stefan; W Mirza; W B Tarver; J F Wernicke
Journal:  Epilepsia       Date:  1994 May-Jun       Impact factor: 5.864

Review 8.  Vagus nerve stimulation therapy, epilepsy, and device parameters: scientific basis and recommendations for use.

Authors:  Christi Heck; Sandra L Helmers; Christopher M DeGiorgio
Journal:  Neurology       Date:  2002-09-24       Impact factor: 9.910

9.  Electrical stimulation of the hippocampal epileptic foci for seizure control: a double-blind, long-term follow-up study.

Authors:  Ana Luisa Velasco; Francisco Velasco; Marcos Velasco; David Trejo; Guillermo Castro; José Damián Carrillo-Ruiz
Journal:  Epilepsia       Date:  2007-07-18       Impact factor: 5.864

10.  Thalamic and limbic involvement in the mechanism of action of vagus nerve stimulation, a SPECT study.

Authors:  Kristl Vonck; Veerle De Herdt; Tommy Bosman; Stefanie Dedeurwaerdere; Koen Van Laere; Paul Boon
Journal:  Seizure       Date:  2008-06-16       Impact factor: 3.184

View more
  8 in total

1.  Ultrasonic neuromodulation by brain stimulation with transcranial ultrasound.

Authors:  Yusuf Tufail; Anna Yoshihiro; Sandipan Pati; Monica M Li; William J Tyler
Journal:  Nat Protoc       Date:  2011-09-01       Impact factor: 13.491

2.  A probabilistic method for determining cortical dynamics during seizures.

Authors:  Vera M Dadok; Heidi E Kirsch; Jamie W Sleigh; Beth A Lopour; Andrew J Szeri
Journal:  J Comput Neurosci       Date:  2015-04-08       Impact factor: 1.621

Review 3.  Developing Collaborative Platforms to Advance Neurotechnology and Its Translation.

Authors:  David A Borton; Heather E Dawes; Gregory A Worrell; Philip A Starr; Timothy J Denison
Journal:  Neuron       Date:  2020-10-28       Impact factor: 17.173

4.  Nerve-muscle activation by rotating permanent magnet configurations.

Authors:  Peter A Watterson; Graham M Nicholson
Journal:  J Physiol       Date:  2016-02-16       Impact factor: 5.182

5.  Neurohemodynamic correlates of 'OM' chanting: A pilot functional magnetic resonance imaging study.

Authors:  Bangalore G Kalyani; Ganesan Venkatasubramanian; Rashmi Arasappa; Naren P Rao; Sunil V Kalmady; Rishikesh V Behere; Hariprasad Rao; Mandapati K Vasudev; Bangalore N Gangadhar
Journal:  Int J Yoga       Date:  2011-01

6.  Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation.

Authors:  Undurti N Das
Journal:  J Inflamm Res       Date:  2010-12-02

7.  Axonal Stimulations With a Higher Frequency Generate More Randomness in Neuronal Firing Rather Than Increase Firing Rates in Rat Hippocampus.

Authors:  Zhaoxiang Wang; Zhouyan Feng; Xuefeng Wei
Journal:  Front Neurosci       Date:  2018-10-24       Impact factor: 4.677

Review 8.  Neuromodulation in Drug Resistant Epilepsy.

Authors:  Natalia Rincon; Donald Barr; Naymee Velez-Ruiz
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.